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Objective: Patients with severe hypernatremia who receive conventional
treatment are often undertreated. Data on the management of acute hyper-
natremia using continuous venovenous hemofiltration (CVVH) are limited to
anecdotes. This study aimed to evaluate the efficacy and safety of CVVH for
acute severe hypernatremia in critically ill patients in a retrospective
cohort.
Methods: A total of 95 patients who admitted to our ICU between January
2009 and January 2014 were analyzed as the original cohort. These patients
were divided into CVVH and conventional treatment groups. The patients in
the conventional and CVVH groups were then matched by age, reason for ICU
admission, vasopressor dependency, basic serum sodium concentration, and
Glasgow scores. A Cox regression model was used to adjust the confounding
variables.0267
0267
Table 1. Independent risk factors of mortality in total patients.
Variables Univariate analysis
HR (95% CI)
Treatment methods
(No-CVVH/CVVH)
1.7 (1.0e2.8)
Mechanical ventilation (Yes/No) 2.4 (1.4e4.3)
Vasopressor dependency (Yes/No) 3.5 (2.1e6.0)
Baseline serum sodium 1.03 (1.00e1.06)
Glasgow score 0.92 (0.87e0.97)Results: The accumulated 7- and 28-day survival rates of all patients were
56.8% and 32.6% (Figure 1A), respectively. In the original cohort, the 28-
day survival rates were 41.9% and 25.0% for the CVVH and conventional
treatment groups (Figure 1B), respectively. Conventional treatment (HR Z
2.1, 95% CI 1.1e3.8, P Z 0.019; Table 1) was an independent predictor of
patient mortality in the multivariate Cox regression model. The accumulated
28-day survival rate was significantly higher among the patients who experi-
enced the 24-hour hypernatremia correction (58.8% vs. 26.9%, P Z 0.020;
Figure 1C). In the matched cohort, the two groups were not significantly
different in terms of baseline characteristics. The CVVH group had a signif-
icantly greater reduction in the serum sodium concentration (0.78 mmol/L/h
vs. 0.13 mmol/L/h, P < 0.001) and an improved 28-day survival rate (34.8%
vs. 8.7%, P Z 0.002; Figure 1D) compared with the conventional treatment
group. The two groups did not differ significantly in treatment-related
complications.
Conclusion: CVVH treatment is possibly more effective than conventional
treatment for the management of acute severe hypernatremia in critically
ill patients.http://dx.doi.org/10.1016/j.hkjn.2015.09.074Multivariate analysis
P value HR (95% CI) P value
0.038 1.8 (1.1e3.0) 0.027
0.002
<0.001 2.5 (1.4e4.5) 0.003
0.027
0.001
